Abstract
DAILY INTAKE OF FRUCTOLIGOSACCHARIDE REDUCES hs-CRP AND OTHER INFLAMMATORY MARKERS IN GRADE 1 SEDENTARY OBESE INDIVIDUALS RESIDING IN URBAN BARODA - A DOUBLE BLIND PLACEBO CONTROL TRIAL.

*Mini Sheth, Swati Parnami, Sania Quraishi, Jyoti Prakash, Anil Kumar, Manish Jain, Manoj Gote, Ashok Dubey

ABSTRACT

Background: Obesity is not an immediate lethal disease in itself but is a significant risk factor associated with a range of serious non-communicable diseases probably due to its association with inflammation of tissues of certain vital organs. Objective: To study the putative role of Fructooligosaccharide in modulation of Gut microflora and thereby affect the levels of inflammatory markers in obese individuals. Methodology: Using a double blind placebo control study design, eighty two sedentary obese subjects in the age group of 20-50 years who voluntarily agreed to participate in the study were purposively selected and were equally divided into two groups who received 10 ml liquid FOS and 10 ml liquid sucrose solution respectively for a period of 30 days. Their serum inflammatory markers in terms of TNF α, Leptin, and IL-6 was determined using Metabolic Hormone Magnetic Bead Panel and hs-CRP was determined using nephelometry method. Assessment of hematological indices was based on the principle of cell counting and volumetric analysis and the fecal bifidobacteria counts were determined using selective medium under anaerobic conditions. Results: Supplementation of liquid FOS significantly reduced the hs-CRP levels by 17.24% with a non-significant reduction in the TNF α, IL6 and Leptin levels was observed by 4.94% and 2.90% respectively. Conclusion: Daily intake of 10g of liquid FOS helps in reducing the low grade inflammation especially in terms of hs CRP and improved bifidobacteria colonisation in sedentary obese individuals and can be used as an effective strategy to delay obesity related co-morbidities.

Keywords: Fructooligosaccharide, bifidobacteria, Gut microflora.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation

  • NEW OCTOBER ISSUE PUBLISHED

    OCTOBER 2020 Issue has been successfully launched on 1 October 2020.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT